Ocular Therapeutix Inc. buy Chardan Capital
Start price
15.09.25
/
50%
€10.62
Target price
15.09.26
€17.90
Performance (%)
-29.59%
Price
13.02.26
€7.47
Summary
This prediction is currently active. The prediction for Ocular Therapeutix Inc. disappoints with a performance of -29.59%. This prediction currently runs until 15.09.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -3.710% | -3.710% |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
Comments by Chardan_Capital for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Chardan_Capital for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€13.61
09.12.25
09.12.25
€18.03
09.12.26
09.12.26
-45.08%
13.02.26
13.02.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.36
05.11.25
05.11.25
€18.27
05.11.26
05.11.26
-20.15%
13.02.26
13.02.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.43
02.10.25
02.10.25
€17.89
02.10.26
02.10.26
-20.71%
13.02.26
13.02.26